HIV Infections Clinical Trials in Los Angeles, California

4 studies are recruiting for hiv infections in Los Angeles, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

   The goal of this observational study is to generate real-life information on the use of lenacapavir (LEN, YEZTUGO®, (YTG)) for pre-exposure prophylaxis (PrEP) across diverse clinical settings in the United States. The study will characterize how PrEP is initiated, used, and discontinued in routine …

   Stage

   Not phased

   Ages

   18 and older

   Site

   Ruane Clinical Research Group Inc., Los Angeles, California

   Locations

   38 in total

   Run by

   Gilead Sciences

   See if you can join NCT07473778 on ClinicalTrials.gov

2. A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

   This study compares the efficacy, safety and tolerability of CAB ULA and RPV ULA administered with CAB long acting (LA) and RPV LA administered in adults and adolescents with HIV who are virologically suppressed on anti-retroviral therapy (ART).

   Stage

   Phase 3

   Ages

   12 and older

   Site

   GSK Investigational Site, Los Angeles, California

   Locations

   88 in total

   Run by

   ViiV Healthcare

   See if you can join NCT07650916 on ClinicalTrials.gov

3. Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

   This is a randomized placebo-controlled study in treated and suppressed HIV-infected individuals aged ≥40 years with either known CVD or 1 CVD risk factor to study the effect of Bempedoic acid (BA) on safety, arterial inflammation as assessed by FDG-PET/CT, lipids, inflammation, immune activation, …

   Stage

   Phase 2

   Ages

   40 and older

   Site

   UCLA Center for Clinical AIDS Research and Education (CARE), Los Angeles, California

   Locations

   3 in total

   Run by

   Priscilla Hsue, MD

   See if you can join NCT05488431 on ClinicalTrials.gov

4. Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically

   Despite the widespread availability of effective antiretroviral therapy (ART) in the United States, there remains significant numbers of people living with HIV (PLWH) who fail to achieve and or maintain viral suppression (VS). Disparities persist with the lowest levels of VS among Black individuals…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of California, Los Angeles, Los Angeles, California

   Run by

   University of California, Los Angeles

   See if you can join NCT06370780 on ClinicalTrials.gov